Rachel Yehuda

Professor of Psychiatry and Neuroscience; Director, Center for Psychedelic Psychotherapy and Trauma Research, Icahn School of Medicine at Mount Sinai

Data updated

Papers

6 publications

Trials

0 clinical trials

Links

Research Footprint

Rachel Yehuda appears in 6 tracked papers (2021–2025), most studied alongside Psilocybin, MDMA and Placebo, across PTSD, Depressive Disorders and Treatment-Resistant Depression (TRD).

Most-cited paper: Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy (70 citations).

Frequent co-authors: Nadav Liam Modlin, James Rucker and Guy Goodwin.

Background & Research

Rachel Yehuda is a prominent neuroscientist and psychiatrist known for her foundational research on traumatic stress, PTSD, intergenerational trauma, and stress biology. She leads Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research, where her group studies MDMA- and psilocybin-assisted treatments for PTSD. She is also a professor at the Icahn School of Medicine at Mount Sinai and has long been associated with trauma research in veterans and other trauma-exposed populations.

Affiliations

Institutions, companies, and organisations Rachel Yehuda is associated with.